ANGELA OWENS: Open Payments
NPI 1326307463 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $317 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $39 |
| Lilly USA, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: QUTENZA, Ozempic, JARDIANCE, Kerendia, Tirosint, CAPLYTA, CAPVAXIVE.
Industry payments across MS — which companies pay providers there.
